# MATERION Corp: financial statements, quarterly

MTRN · NYSE · CIK 1104657 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mtrn.md) · [Financials](/companies/mtrn/financials.md) · [Filings](/companies/mtrn/filings.md) · [Insiders](/companies/mtrn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mtrn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [403](/filings/0001104657-24-000146.md) | [421 d](/filings/0001104657-26-000011.md) | [385](/filings/0001104657-25-000059.md) | [426](/filings/0001104657-25-000144.md) | [437](/filings/0001104657-25-000191.md) | [437 d](/filings/0001104657-26-000011.md) | [420](/filings/0001104657-26-000029.md) | [432](/filings/0001104657-26-000044.md) | [445](/filings/0001104657-25-000191.md) | [490 d](/filings/0001104657-26-000011.md) | [550](/filings/0001104657-26-000029.md) | [614](/filings/0001104657-26-000044.md) |
| Cost of revenue | $m | [314](/filings/0001104657-24-000146.md) | [341 d](/filings/0001104657-26-000011.md) | [314](/filings/0001104657-25-000059.md) | [345](/filings/0001104657-25-000144.md) | [356](/filings/0001104657-25-000191.md) | [344 d](/filings/0001104657-26-000011.md) | [344](/filings/0001104657-26-000029.md) | [349](/filings/0001104657-26-000044.md) | [359](/filings/0001104657-25-000191.md) | [426 d](/filings/0001104657-26-000011.md) | [468](/filings/0001104657-26-000029.md) | [510](/filings/0001104657-26-000044.md) |
| Gross profit | $m | [88.9](/filings/0001104657-24-000146.md) | [79.7 d](/filings/0001104657-26-000011.md) | [71.2](/filings/0001104657-25-000059.md) | [80.9](/filings/0001104657-25-000144.md) | [80.9](/filings/0001104657-25-000191.md) | [93.0 d](/filings/0001104657-26-000011.md) | [76.2](/filings/0001104657-26-000029.md) | [82.7](/filings/0001104657-26-000044.md) | [86.1](/filings/0001104657-25-000191.md) | [63.7 d](/filings/0001104657-26-000011.md) | [81.8](/filings/0001104657-26-000029.md) | [104](/filings/0001104657-26-000044.md) |
| Research and development | $m | [6.3](/filings/0001104657-24-000146.md) | [6.4 d](/filings/0001104657-26-000011.md) | [7.1](/filings/0001104657-25-000059.md) | [7.7](/filings/0001104657-25-000144.md) | [7.9](/filings/0001104657-25-000191.md) | [6.3 d](/filings/0001104657-26-000011.md) | [6.5](/filings/0001104657-26-000029.md) | [6.4](/filings/0001104657-26-000044.md) | [6.5](/filings/0001104657-25-000191.md) | [6.5 d](/filings/0001104657-26-000011.md) | [6.2](/filings/0001104657-26-000029.md) | [6.6](/filings/0001104657-26-000044.md) |
| Selling, general and administrative | $m | [38.8](/filings/0001104657-24-000146.md) | [39.9 d](/filings/0001104657-26-000011.md) | [35.8](/filings/0001104657-25-000059.md) | [33.6](/filings/0001104657-25-000144.md) | [35.0](/filings/0001104657-25-000191.md) | [41.1 d](/filings/0001104657-26-000011.md) | [35.4](/filings/0001104657-26-000029.md) | [35.0](/filings/0001104657-26-000044.md) | [38.3](/filings/0001104657-25-000191.md) | [34.3 d](/filings/0001104657-26-000011.md) | [36.2](/filings/0001104657-26-000029.md) | [42.3](/filings/0001104657-26-000044.md) |
| Operating income | $m | [36.5](/filings/0001104657-24-000146.md) | [27.6 d](/filings/0001104657-26-000011.md) | [22.2](/filings/0001104657-25-000059.md) | [32.1](/filings/0001104657-25-000144.md) | [31.3](/filings/0001104657-25-000191.md) | [(38.3) d](/filings/0001104657-26-000011.md) | [27.2](/filings/0001104657-26-000029.md) | [36.8](/filings/0001104657-26-000044.md) | [34.9](/filings/0001104657-25-000191.md) | [10.8 d](/filings/0001104657-26-000011.md) | [28.2](/filings/0001104657-26-000029.md) | [51.7](/filings/0001104657-26-000044.md) |
| Interest expense | $m | [7.7](/filings/0001104657-23-000155.md) | [8.5 d](/filings/0001104657-26-000011.md) | [8.3](/filings/0001104657-25-000059.md) | [8.8](/filings/0001104657-25-000144.md) | [8.8](/filings/0001104657-25-000191.md) | [8.8 d](/filings/0001104657-26-000011.md) | [6.9](/filings/0001104657-26-000029.md) | [8.2](/filings/0001104657-26-000044.md) | [7.5](/filings/0001104657-25-000191.md) | [8.0 d](/filings/0001104657-26-000011.md) | [7.6](/filings/0001104657-26-000029.md) | [7.5](/filings/0001104657-26-000044.md) |
| Income tax | $m | [3.0](/filings/0001104657-24-000146.md) | [0.2 d](/filings/0001104657-26-000011.md) | [1.2](/filings/0001104657-25-000059.md) | [4.9](/filings/0001104657-25-000144.md) | [0.8](/filings/0001104657-25-000191.md) | [2.2 d](/filings/0001104657-26-000011.md) | [3.2](/filings/0001104657-26-000029.md) | [4.0](/filings/0001104657-26-000044.md) | [2.7](/filings/0001104657-25-000191.md) | [(3.2) d](/filings/0001104657-26-000011.md) | [1.5](/filings/0001104657-26-000029.md) | [5.7](/filings/0001104657-26-000044.md) |
| Net income | $m | [26.6](/filings/0001104657-24-000146.md) | [19.5 d](/filings/0001104657-26-000011.md) | [13.4](/filings/0001104657-25-000059.md) | [19.0](/filings/0001104657-25-000144.md) | [22.3](/filings/0001104657-25-000191.md) | [(48.9) d](/filings/0001104657-26-000011.md) | [17.7](/filings/0001104657-26-000029.md) | [25.1](/filings/0001104657-26-000044.md) | [25.4](/filings/0001104657-25-000191.md) | [6.6 d](/filings/0001104657-26-000011.md) | [19.4](/filings/0001104657-26-000029.md) | [38.8](/filings/0001104657-26-000044.md) |
| Diluted EPS | $ per share | [1.27](/filings/0001104657-24-000146.md) | not reported | [0.64](/filings/0001104657-25-000059.md) | [0.91](/filings/0001104657-25-000144.md) | [1.07](/filings/0001104657-25-000191.md) | not reported | [0.85](/filings/0001104657-26-000029.md) | [1.21](/filings/0001104657-26-000044.md) | [1.22](/filings/0001104657-25-000191.md) | not reported | [0.92](/filings/0001104657-26-000029.md) | [1.84](/filings/0001104657-26-000044.md) |
| Basic EPS | $ per share | [1.29](/filings/0001104657-24-000146.md) | not reported | [0.65](/filings/0001104657-25-000059.md) | [0.92](/filings/0001104657-25-000144.md) | [1.07](/filings/0001104657-25-000191.md) | not reported | [0.85](/filings/0001104657-26-000029.md) | [1.21](/filings/0001104657-26-000044.md) | [1.23](/filings/0001104657-25-000191.md) | not reported | [0.93](/filings/0001104657-26-000029.md) | [1.86](/filings/0001104657-26-000044.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-29) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [16.4](/filings/0001104657-23-000155.md) | [13.3](/filings/0001104657-25-000024.md) | [13.1](/filings/0001104657-24-000066.md) | [17.1](/filings/0001104657-24-000116.md) | [17.9](/filings/0001104657-24-000146.md) | [16.7](/filings/0001104657-26-000011.md) | [15.6](/filings/0001104657-25-000059.md) | [12.6](/filings/0001104657-25-000144.md) | [16.4](/filings/0001104657-25-000191.md) | [13.7](/filings/0001104657-26-000044.md) | [16.2](/filings/0001104657-26-000029.md) | [20.0](/filings/0001104657-26-000044.md) |
| Current assets | $m | [710](/filings/0001104657-23-000155.md) | [709](/filings/0001104657-25-000024.md) | [740](/filings/0001104657-24-000066.md) | [739](/filings/0001104657-24-000116.md) | [795](/filings/0001104657-24-000146.md) | [724](/filings/0001104657-26-000011.md) | [759](/filings/0001104657-25-000059.md) | [735](/filings/0001104657-25-000144.md) | [776](/filings/0001104657-25-000191.md) | [790](/filings/0001104657-26-000044.md) | [876](/filings/0001104657-26-000029.md) | [870](/filings/0001104657-26-000044.md) |
| Total assets | $m | [1,749](/filings/0001104657-23-000155.md) | [1,763](/filings/0001104657-25-000024.md) | [1,805](/filings/0001104657-24-000066.md) | [1,804](/filings/0001104657-24-000116.md) | [1,857](/filings/0001104657-24-000146.md) | [1,698](/filings/0001104657-26-000011.md) | [1,752](/filings/0001104657-25-000059.md) | [1,741](/filings/0001104657-25-000144.md) | [1,793](/filings/0001104657-25-000191.md) | [1,803](/filings/0001104657-26-000044.md) | [1,877](/filings/0001104657-26-000029.md) | [1,871](/filings/0001104657-26-000044.md) |
| Current liabilities | $m | [217](/filings/0001104657-23-000155.md) | [255](/filings/0001104657-25-000024.md) | [255](/filings/0001104657-24-000066.md) | [227](/filings/0001104657-24-000116.md) | [253](/filings/0001104657-24-000146.md) | [227](/filings/0001104657-26-000011.md) | [267](/filings/0001104657-25-000059.md) | [232](/filings/0001104657-25-000144.md) | [236](/filings/0001104657-25-000191.md) | [254](/filings/0001104657-26-000044.md) | [288](/filings/0001104657-26-000029.md) | [296](/filings/0001104657-26-000044.md) |
| Long-term debt | $m | [425](/filings/0001104657-23-000155.md) | [388](/filings/0001104657-25-000024.md) | [429](/filings/0001104657-24-000066.md) | [446](/filings/0001104657-24-000116.md) | [458](/filings/0001104657-24-000146.md) | [408](/filings/0001104657-26-000011.md) | [399](/filings/0001104657-25-000059.md) | [406](/filings/0001104657-25-000144.md) | [447](/filings/0001104657-25-000191.md) | [436](/filings/0001104657-26-000044.md) | [467](/filings/0001104657-26-000029.md) | [423](/filings/0001104657-26-000044.md) |
| Current portion of debt | $m | [38.6](/filings/0001104657-23-000155.md) | [38.6](/filings/0001104657-25-000024.md) | [46.6](/filings/0001104657-24-000066.md) | [38.8](/filings/0001104657-24-000116.md) | [37.5](/filings/0001104657-24-000146.md) | [34.3](/filings/0001104657-26-000011.md) | [52.6](/filings/0001104657-25-000059.md) | [19.9](/filings/0001104657-25-000144.md) | [10.2](/filings/0001104657-25-000191.md) | [22.4](/filings/0001104657-26-000044.md) | [23.1](/filings/0001104657-26-000029.md) | [17.5](/filings/0001104657-26-000044.md) |
| Short-term borrowings | $m | [38.6](/filings/0001104657-23-000155.md) | [38.6](/filings/0001104657-25-000024.md) | [46.6](/filings/0001104657-24-000066.md) | [38.8](/filings/0001104657-24-000116.md) | [37.5](/filings/0001104657-24-000146.md) | [34.3](/filings/0001104657-26-000011.md) | [52.6](/filings/0001104657-25-000059.md) | [19.9](/filings/0001104657-25-000144.md) | [10.2](/filings/0001104657-25-000191.md) | [22.4](/filings/0001104657-26-000044.md) | [23.1](/filings/0001104657-26-000029.md) | [17.5](/filings/0001104657-26-000044.md) |
| Shareholders' equity | $m | [872](/filings/0001104657-24-000146.md) | [885](/filings/0001104657-26-000011.md) | [890](/filings/0001104657-25-000144.md) | [907](/filings/0001104657-25-000191.md) | [932](/filings/0001104657-25-000191.md) | [869](/filings/0001104657-26-000044.md) | [888](/filings/0001104657-26-000044.md) | [911](/filings/0001104657-26-000044.md) | [935](/filings/0001104657-25-000191.md) | [943](/filings/0001104657-26-000044.md) | [957](/filings/0001104657-26-000044.md) | [995](/filings/0001104657-26-000044.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [14.0 d](/filings/0001104657-24-000146.md) | [59.9 d](/filings/0001104657-26-000011.md) | [(13.8)](/filings/0001104657-25-000059.md) | [20.3 d](/filings/0001104657-25-000144.md) | [5.1 d](/filings/0001104657-25-000191.md) | [76.3 d](/filings/0001104657-26-000011.md) | [15.5](/filings/0001104657-26-000029.md) | [49.9 d](/filings/0001104657-26-000044.md) | [18.3 d](/filings/0001104657-25-000191.md) | [19.5 d](/filings/0001104657-26-000011.md) | [(4.3)](/filings/0001104657-26-000029.md) | [74.8 d](/filings/0001104657-26-000044.md) |
| Capital expenditure | $m | not reported | [25.3 d](/filings/0001104657-25-000024.md) | [21.3](/filings/0001104657-25-000059.md) | not reported | not reported | [17.9 d](/filings/0001104657-25-000024.md) | [12.3](/filings/0001104657-26-000029.md) | not reported | not reported | not reported | [15.3](/filings/0001104657-26-000029.md) | not reported |
| Dividends paid | $m | [2.7 d](/filings/0001104657-24-000146.md) | [2.7 d](/filings/0001104657-26-000011.md) | [2.7](/filings/0001104657-25-000059.md) | [2.8 d](/filings/0001104657-25-000144.md) | [2.8 d](/filings/0001104657-25-000191.md) | [2.8 d](/filings/0001104657-26-000011.md) | [2.8](/filings/0001104657-26-000029.md) | [2.9 d](/filings/0001104657-26-000044.md) | [2.9 d](/filings/0001104657-25-000191.md) | [2.9 d](/filings/0001104657-26-000011.md) | [2.9](/filings/0001104657-26-000029.md) | [3.0 d](/filings/0001104657-26-000044.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001104657-25-000191.md) | [0.0 d](/filings/0001104657-26-000011.md) | not reported | not reported | [0.0 d](/filings/0001104657-25-000191.md) | [0.0 d](/filings/0001104657-26-000011.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.8](/filings/0001104657-23-000155.md) | [20.9](/filings/0001104657-24-000066.md) | [20.9](/filings/0001104657-24-000116.md) | [20.9](/filings/0001104657-24-000146.md) | [21.0](/filings/0001104657-25-000059.md) | [20.9](/filings/0001104657-25-000144.md) | [20.9](/filings/0001104657-25-000191.md) | [20.9](/filings/0001104657-26-000029.md) | [20.8](/filings/0001104657-26-000044.md) | [20.9](/filings/0001104657-25-000191.md) | [21.0](/filings/0001104657-26-000029.md) | [21.1](/filings/0001104657-26-000044.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,833,725 at 2026-07-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001104657-26-000044.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.